OncoSil Medical (ASX:OSL) Beginning Cash Position : A$4.71 Mil (As of Jun. 2024)

View and export this data going back to 2005. Start your Free Trial

What is OncoSil Medical Beginning Cash Position?

OncoSil Medical's Beginning Cash Position for the quarter that ended in Jun. 2024 was A$4.71 Mil.

OncoSil Medical's quarterly Beginning Cash Position increased from Jun. 2023 (A$5.76 Mil) to Dec. 2023 (A$9.39 Mil) but then declined from Dec. 2023 (A$9.39 Mil) to Jun. 2024 (A$4.71 Mil).

OncoSil Medical's annual Beginning Cash Position declined from Jun. 2022 (A$12.24 Mil) to Jun. 2023 (A$11.28 Mil) and declined from Jun. 2023 (A$11.28 Mil) to Jun. 2024 (A$9.39 Mil).

OncoSil Medical Beginning Cash Position Historical Data

The historical data trend for OncoSil Medical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSil Medical Beginning Cash Position Chart

OncoSil Medical Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Beginning Cash Position

Get a 7-Day Free Trial

7.69

21.00

12.24

11.28

9.39

OncoSil Medical Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Beginning Cash Position	Get a 7-Day Free Trial															6.66	11.28	5.76	9.39	4.71

OncoSil Medical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

OncoSil Medical Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of OncoSil Medical's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoSil Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OncoSil Medical Ltd (ASX:OSL) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eden Park Drive, Level 5, Macquarie Park, Sydney, NSW, AUS, 2113

Website

https://www.oncosil.com

OncoSil Medical Ltd is a medical device company. It is engaged in the development and commercialization of its product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. It operates in one segment. the device development for new medical treatments. Geographically, the company derives its maximum revenue from Europe and the rest from Australia and New Zealand.

OncoSil Medical Headlines

No Headlines